During the past decade, Waterloo Medical Centre conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Waterloo Medical Centre" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "George Medicines PTY Limited" with 1 trials sponsored, "Ipsen" with 1 trials sponsored, "Kowa Research Institute, Inc." with 1 trials sponsored and "Sankyo Pharma Gmbh" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Waterloo Medical Centre" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Waterloo Medical Centre" are "Diabetes Mellitus, Type 2" (1 trials), "Dyslipidemia" (1 trials), "Essential Hypertension" (1 trials), "Hypertension" (1 trials) and "Obesity" (1 trials). Many other conditions were trialed in "Waterloo Medical Centre" in a lesser frequency.

Most popular intervention types in "Waterloo Medical Centre" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "BI 456906" (2 trials), "Amlodipine 2.5 mg/indapamide 1.25 mg" (1 trials), "Decapeptyl® SR 11.25mg; Prostap® 3 DCS 11.25mg; Zoladex® LA 10.8mg" (1 trials) and "Decapeptyl® SR 22.5mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Waterloo Medical Centre" are 5 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Waterloo Medical Centre". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Waterloo Medical Centre, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Waterloo Medical Centre, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".